RE: Blue11 Nov 2025 10:58
RNS 5 Nov 2025: Good progress in the UK as well as the USA. 'Global' ambitions! Could start to get exciting here.....
Commenting, Allan Syms, Executive Chairman of Cizzle Biotechnology, said:
We are excited to report we have now entered a LOI with a leading UK provider with partnerships with NHS Foundation Trusts. Our goal is to provide a first-class service to help drive early cancer detection at scale globally. We are now pleased that the UK will be the next phase of our growth plans in making the test available to many patients as soon as possible.
The Company will also continue to focus on supporting its US partner Cizzle BIO Inc, to secure CLIA accreditation to take the test live in the near term